The women’s health and wellness space is booming. The opportunities are real and so are the rewards. This is where you keep up. Welcome to The DXF Edit.
A woman in Illinois followed every rule, lived in a protective state, and still lost her fallopian tube. State courts are blocking abortion rights not by ruling against them, but by making them impossible to reach. Meanwhile, women’s health just produced its first unicorns, an insurer is funding menopause care, and a doctor reframed menopause in terms the internet couldn’t ignore.
MONEY MOVES
Women’s Health Finally Has Its Unicorns. And They’re Not Fertility Companies.
Menopause care and maternal health just out-invested fertility. Midi Health and Pomelo Care both crossed unicorn status in early 2026, and together they represent more than 50% of last year’s total healthtech investment in women’s health, per SVB’s Women’s Health Innovation Report. Not a fertility app in sight.
For years, the women’s health investment narrative began and ended with IVF tech and cycle tracking. What Midi and Pomelo prove is that the money has moved. To menopause, to maternal health, to the conditions that have been dismissed as too niche or too complicated for too long.
This is infrastructure, not wellness. Both platforms run on insurance reimbursement, employer partnerships, and clinical care models. That’s the blueprint investors have been waiting for.
Women’s health VC hit $2.6 billion in 2024, a 55% year-over-year jump. Women are also the fastest-growing wealth demographic in the world. Those two facts are not unrelated.
When an Insurer Leads a Women’s Health Round, Everyone Should Pay Attention.
When a venture capitalist backs a women’s health company, it’s a bet. When an insurer does it, it’s a calculation.
Canadian women’s health platform June Health closed an oversubscribed C$2.4M round this week, led by Securian Canada, a major Canadian insurance provider. The platform delivers menopause and reproductive health care as an employer benefit, a model that’s becoming the dominant playbook for women’s health companies on both sides of the border.
Like the US, Canada relies on private employer-sponsored insurance to cover women’s health beyond basic care. Menopause treatment, reproductive health, prescription drugs, none of it falls under universal coverage. Securian is moving on the same benefits gap US insurers have been slow to touch.
The employer benefits model is becoming women’s health’s most reliable funding path. Insurers are starting to move on it too.
INNOVATION
Natural Cycles Is Connecting the Dots Between Your Hormones and Your Sleep
Most sleep tools treat every night the same. Your body doesn’t. Natural Cycles, the first FDA-cleared birth control app, launched Sleep Insights this week. The feature connects cycle phase data with sleep quality metrics from Oura Ring, NC Band, Garmin, and Apple Watch. It’s the first time a contraceptive app has directly linked hormonal data to sleep tracking in a single platform.
Here’s what most women don’t know: the relationship between sleep and hormones runs both ways. Yes, your cycle affects your sleep. But poor sleep also actively disrupts your hormonal health. Chronic sleep deprivation raises cortisol, suppresses the luteinizing hormone critical for ovulation, and has been linked to irregular cycles, worsened PMS, and accelerated perimenopause symptoms.
Sleep Insights gives women the data to see the connection in real time, understand what’s hormonal versus lifestyle, and make informed decisions about their health across the month.
Real-Time Glucose Monitoring Is Now Over the Counter. No Doctor Required.
Ultrahuman launched M2 Live in the U.S. this week, integrating Abbott’s Lingo CGM into its metabolic health platform. No prescription required. Sensors start at $99/month.
Until now, continuous glucose monitors were prescription-only tools designed for diabetes management. The OTC version changes the access model entirely. It doesn’t flag dangerous blood sugar highs and lows the way prescription CGMs do, it’s built for metabolic insight, not medical management. That means tracking in real time how food, sleep, stress, and exercise move your glucose, without needing to see a doctor first.
For women, that distinction matters more than it might seem. Menopause directly disrupts metabolic health, altering how the body processes glucose and increasing the risk of prediabetes. One in three Americans already has prediabetes and doesn’t qualify for a prescription CGM. Women going through perimenopause and menopause are navigating a metabolic shift that most of their healthcare hasn’t accounted for.
M2 Live connects glucose data to HRV, sleep, and skin temperature, built on a Metabolic Score validated across nine clinical centers and published in Scientific Reports.
LAW & POLICY
She Lost Her Only Fallopian Tube in Illinois. Now She’s Suing.
Harmonie Perrone, 28, went to an Illinois hospital with a life-threatening ectopic pregnancy. She was turned away. Twice. Her OB-GYN, practicing at Advocate Good Shepherd Hospital, an Ascension-affiliated facility, cited a “1% chance” of viability and refused to administer methotrexate. Illinois state law explicitly protects abortion access for emergency conditions including ectopic pregnancies. None of that mattered. Perrone’s tube ruptured. She lost her last remaining fallopian tube. She will need IVF to conceive.
She is now suing for damages to cover IVF costs and for the pain and suffering caused when, in her words, medical providers substituted their own values for hers.
This happened in Illinois, one of the most abortion-protective states in the country. Not Texas. Not Alabama. Illinois. The case exposes a gap that legal protections alone cannot close: when a religiously affiliated hospital system operates inside a protective state, the law on paper and the care available in practice can be two entirely different things.
Living in a protective state is not the same as being protected.
State Courts Have Found a New Way to Limit Abortion Rights. Without Ruling on the Merits.
Anti-abortion lawmakers don’t always need to win on the law. Sometimes they just need to make the law unreachable.
A new analysis published by State Court Report this week documents a quiet but significant legal tactic: hostile state courts are using procedural hurdles to block abortion rights litigation without ever ruling on whether those rights exist. No ruling on the merits. No definitive decision. Just process used as a weapon.
In Georgia, the Supreme Court vacated a ruling against the six-week ban not on constitutional grounds, but by changing its standing doctrine. In Missouri, the court used the standard for granting a preliminary injunction to reinstate abortion bans that a lower court had already blocked as unconstitutional. In North Dakota, a supermajority requirement meant that even though three of five justices found the abortion ban unconstitutionally vague, it wasn’t enough to strike it down.
The result: abortion rights that exist in state constitutions are becoming structurally inaccessible. The rights are there. Getting to them is not.
ON THE FEED
The Doctor Who Called Menopause a Castration Event Just Changed the Conversation
A urologist went on one of the world’s biggest podcasts this week and said what most doctors won’t.
Dr. Rachel Rubin, sexual medicine specialist, appeared on The Diary of a CEO with Steven Bartlett and reframed menopause in terms that stopped the internet cold. Her argument: menopause is the hormonal equivalent of surgical castration. If men had their testes removed, they would experience the same symptoms women navigate in their fifties. We would never allow that without immediate, aggressive medical intervention. We call it natural when it happens to women.
The episode went viral almost immediately. Because she isn’t saying anything medically controversial. She is saying something culturally explosive: that the medical system has accepted a level of suffering in women that it would never tolerate elsewhere, and has dressed it up as biology.
Menopause has been treated like a dimmer switch being turned down slightly. It’s actually a full power cut.
Women Are Opting Out of Wellness Culture. The Industry Didn’t See It Coming.
Women are pushing back against the version of wellness that was sold to them.
A growing counter-narrative is taking hold online, driven largely by women rejecting biohacking culture, data fatigue, and the pressure to track, measure, and improve every aspect of their health. Somatic release, rest as resistance, and regulation over results are trending across TikTok and Instagram. The message is pointed: wellness built around performance metrics is just another form of pressure wearing a different label.
The timing is notable. The femtech wearable market is expanding rapidly, with new devices launching regularly promising to track everything from hormones to stress to sleep quality. The accuracy of some of these devices remains questionable, but the commercial incentive to sell women another thing to monitor is not. The industry keeps building. Women are starting to ask who it’s actually being built for.
The Global Wellness Summit’s 2026 trend report flagged this shift as one of the defining movements of the year. Women are not rejecting health. They are rejecting the version of health that feels like a performance review.